<img src="https://trc.taboola.com/1321591/log/3/unip?en=page_view" width="0" height="0" style="display:none">
Fact Check Library

Fact Check with Logically.

Download the Free App Today

false
false

CLAIM ID

38dc448d

The Johnson & Johnson COVID-19 vaccine contains aborted fetal cells.

The vaccine developed by Johnson & Johnson does not contain cells from aborted fetuses.

The vaccine developed by Johnson & Johnson does not contain cells from aborted fetuses.COVID-19 vaccines have been at the center of misinformation and disinformation campaigns since they were developed. This includes a false claim that individuals should avoid the J&J vaccine as it's manufactured using cells from an aborted fetus.

The J&J COVID-19 vaccine is created by growing a modified virus in cells originally derived from a retinal cell line that was isolated from an aborted fetus in 1985. Cells from the fetus have been replicated over the decades, creating what’s known as cell strains. So the actual cells used in the manufacture of this vaccine are not directly from a fetus. Any vaccine that relies on these historic cell lines will not require the use of aborted fetuses.

Johnson & Johnson has also issued a statement saying that there is no fetal tissue in its COVID-19 vaccine. Therefore, although fetal cell lines may be used to develop or manufacture COVID-19 vaccines it is false to say that the vaccine itself contains cells from fetuses.

The COVID-19 pandemic has given rise to a lot of potentially dangerous misinformation. For reliable advice on COVID-19 including symptoms, prevention and available treatment, please refer to the World Health Organisation or your national healthcare authority.

Have a question or correction?

Please tell us if you think this claim had been misjudged or requires correction by sending us evidence to support your error claim. We will revisit our evidence and verdict and do some additional research to double check if we can verify the new information

Fact Check of the Day

false

2000 mg of Lysine protects against COVID-19.